nach oben

Rheumatology International

Erschienen in:

01.03.2020 | Correspondence

Comment on “Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis”

verfasst von: Erkan Cure, Medine Cumhur Cure

Erschienen in: Rheumatology International | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

Végh E, Kerekes G, Pusztai A et al (2019) Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis. Rheumatol Int 1:4. https://doi.org/10.1007/s00296-019-04497-0 CrossRef

Cure E, Icli A, Uslu AU et al (2018) Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis: AIP associate with cIMT in AS. Clin Rheumatol 37:1273–1280. https://doi.org/10.1007/s10067-018-4027-0 CrossRefPubMed

Turkyilmaz AK, Devrimsel G, Kirbas A, Cicek Y, Karkucak M, Capkin E, Gokmen F (2013) Relationship between pulse wave velocity and serum YKL-40 level in patients with early rheumatoid arthritis. Rheumatol Int 33:2751–2756. https://doi.org/10.1007/s00296-013-2810-4 CrossRefPubMed

Cure E, Icli A, Ugur Uslu A et al (2017) Atherogenic index of plasma may be strong predictor of subclinical atherosclerosis in patients with Behçet disease. Z Rheumatol 76:259–266. https://doi.org/10.1007/s00393-016-0141-z CrossRefPubMed

Herder M, Johnsen SH, Arntzen KA et al (2012) Risk factors for progression of carotid intima-media thickness and total plaque area: a 13-year follow-up study: the Tromsø Study. Stroke 43:1818–1823. https://doi.org/10.1161/STROKEAHA.111.646596 CrossRefPubMed

Rosvall M, Persson M, Östling G et al (2015) Risk factors for the progression of carotid intima-media thickness over a 16-year follow-up period: the Malmö Diet and Cancer Study. Atherosclerosis 239:615–621. https://doi.org/10.1016/j.atherosclerosis.2015.01.030 CrossRefPubMed

Lorenz MW, Price JF, Robertson C et al (2015) Carotid intima-media thickness progression and risk of vascular events in people with diabetes: results from the PROG-IMT collaboration. Diabetes Care 38:1921–1929. https://doi.org/10.2337/dc14-2732 CrossRefPubMedPubMedCentral

Stanek A, Cholewka A, Wielkoszyński T, Romuk E, Sieron K, Sieron A (2017) Increased levels of oxidative stress markers, soluble CD40 ligand, and carotid intima-media thickness reflect acceleration of atherosclerosis in male patients with ankylosing spondylitis in active phase and without the classical cardiovascular risk factors. Oxid Med Cell Longev 2017:9712536. https://doi.org/10.1155/2017/9712536 CrossRefPubMedPubMedCentral

Biskup M, Biskup W, Majdan M, Targonska-Stępniak B (2018) Cardiovascular system changes in rheumatoid arthritis patients with continued low disease activity. Rheumatol Int 38:1207–1215. https://doi.org/10.1007/s00296-018-4053-x CrossRefPubMedPubMedCentral

10.

Zardi EM, Pipita ME, Giorgi C, Lichinchi D, Zardi DM, Afeltra A (2018) Differences in carotid atherosclerosis between patients with ankylosing spondylitis treated with tumor necrosis factor-α antagonists and healthy matched controls. Medicine (Baltimore) 97:e11250. https://doi.org/10.1097/MD.0000000000011250 CrossRef

Titel: Comment on “Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis”
verfasst von: Erkan Cure
Medine Cumhur Cure
Publikationsdatum: 01.03.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: Rheumatology International / Ausgabe 3/2020
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-020-04513-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 | Hypertonie | Nachrichten

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 | Parkinson-Krankheit | Nachrichten

Viel Bewegung in der Parkinsonforschung

25.04.2024 | Nierenkarzinom | Nachrichten

Adjuvante Immuntherapie verlängert Leben bei RCC

weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

A prospective, longitudinal monocentric study on laser Doppler imaging of microcirculation: comparison with macrovascular pathophysiology and effect of adalimumab treatment in early rheumatoid arthritis

Effect of TNF inhibitors on bone mineral density in rheumatoid arthritis patients receiving bisphosphonate: a retrospective cohort study

Prevalence and clinical presentation of lymphoproliferative disorder in patients with primary Sjögren’s syndrome

Periodontal disease and influence of periodontal treatment on disease activity in patients with rheumatoid arthritis and spondyloarthritis

Positive conversion of interferon-γ release assay in patients with rheumatic diseases treated with biologics

Cardiovascular risk factors’ behavior during the early stages of the disease, in Hispanic rheumatoid arthritis patients: a cohort study